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ABSTRACT: Folding dynamics are ubiquitously involved in
controlling the multivariate functions of RNAs. While the high
thermodynamic stabilities of some RNAs favor purely native
states at equilibrium, it is unclear whether weakly stable RNAs
exist in random, partially folded states or sample well-defined,
globally folded conformations. Using a folding assay that precisely
tracks the formation of native aminoacylable tRNA, we show that
the folding of a weakly stable human mitochondrial (hmt) leucine
tRNA is hierarchical with a distinct kinetic folding intermediate.
The stabilities of the native and intermediate conformers are
separated by only about 1.2 kcal/mol, and the species are readily
interconvertible. Comparison of folding dynamics between
unmodified and fully modified tRNAs reveals that post-transcrip-
tional modifications produce a more constrained native structure
that does not sample intermediate conformations. These structural dynamics may thus be crucial for recognition by some
modifying enzymes in vivo, especially those targeting the globular core region, by allowing access to pretransition state
conformers. Reduced conformational sampling of the native, modified tRNAs could then permit improved performance in
downstream processes of translation. More generally, weak stabilities of small RNAs that fold in the absence of chaperone
proteins may facilitate conformational switching that is central to biological function.
The structural dynamics of RNAs play critical roles in pre-mRNA splicing,1 ribosome assembly,2 virus replication,3
and gene regulation by metabolite-responsive riboswitches.4
Although proteins may bind either transiently or tightly to
facilitate these RNA structural transitions,5,6 the ability to
traverse varied conformational space is a fundamental property of
RNAs.7,8 Indeed, in vitro folding studies have demonstrated that
RNAs in general fold through rugged folding landscapes with
several energetic minima, implying the existence of distinct stable
conformations during folding. Exchange among these con-
formations can be slow or limited, however, because of strong
local base-pairing and stacking interactions present in each state.9
Fundamental insight into RNA folding dynamics requires an
understanding of both thermodynamic and kinetic aspects of the
process. A key role is played by diffuse and site-specific Mg2+
ions.10 For several RNAs, Mg2+-induced folding is hierarchical
with distinct folding intermediates, and the rate-limiting step
occurs late in the folding pathway.11 The magnitude of the
energetic barrier between the late intermediate and final native
states then determines the kinetics of folding. In the Tetrahymena
self-splicing RNA, the rate by which a late intermediate is
converted to the native state is decreased at high Mg2+
concentration, presumably because the intermediate is stabilized
under these conditions.12 Determining the stability of the native
RNA relative to the last populated kinetic intermediate is a
primary goal of RNA folding studies since this controls which
species predominates at equilibrium.11
A common approach to determine the stability of structured
RNAs is the monitoring of structure formation at specified Mg2+
concentrations, using biophysical methods such as gel shift, UV-
absorbance or fluorescence. The Mg2+ dependencies are then
used to calculate Hill coefficients, from which estimates of
stability of the RNAs are obtained. However, Mg2+-induced
folding can yield a variety of different structural intermediates
possessing similar free energies.13,14 Thus, these methods cannot
accurately determine the relative stabilities of native versus
intermediate states for structured RNAs, without an implicit two
state-assumption.15,16 In contrast, by employing a combination
of strategies, the native state of the catalytic domain of bacterial
RNase P was found to be about 50-fold (2 kcal/mol) more stable
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than a kinetic intermediate,17 whereas that of the Tetrahymena
group I ribozyme was 3.5 to 7 kcal/mol more stable.18 Both of
these large RNA intermediates also refold slowly to the native
state, indicating the existence of kinetic barriers.17,19,20 These
barriers may also prevent unfolding of the native state to the
intermediate in a simple two-step reaction model, where the
states possess comparable stabilities.21
Small RNAs are known to form kinetically trapped
intermediates during folding. Several misfold under low salt
and low temperature conditions, and then readily convert to
native forms when heated or when the ionic strength is
increased.22−24 For example, E. coli tRNATrp and 5S rRNA
exist in both active and inactive forms that require high activation
energies for interconversion.22,25−27 While no experimentally
determined values for the relative stabilities of native versus
intermediate states currently exist for these RNAs, it may be
reasonable to assume that they populate the native states nearly
exclusively if these states are highly stable. However, for RNAs
that possess relatively weak global stabilities, it is unclear what
native and non-native conformations are populated and how
folding dynamics in turn affects function. The dynamic motions
of small RNAs have been studied by a variety of methods;28,29 for
example, single-molecule fluorescence resonance energy transfer
(smFRET) studies demonstrated that the hairpin, hammerhead,
and Tetrahymena ribozymes each interconvert among different
functional conformational states at equilibrium.30−33 However,
smFRET does not distinguish between native and non-native
states of an RNA because their structural signatures can be highly
similar.20,34,35 Additionally, because the non-native states retain
many native tertiary contacts, these methods require prior
knowledge about the folding pathways to elucidate the
conformational transitions that occur between the native and
non-native states. A direct assay of the native state achieved by
exploiting catalytic properties of the RNA alone, or a protein
enzyme that acts upon it, is therefore desirable.
Previously, we developed such a strategy to accurately monitor
the kinetics and thermodynamics of tRNA folding based on the
ability of 32P-labeled tRNAs to be aminoacylated.36 We now
apply this approach to probe the folding of a highly destabilized
disease-relevant mitochondrial tRNA. Mitochondrial tRNAs are
good models for studying the effects of weakly stable native
structure on the functional properties of the molecule since many
of them lack key conserved structural elements found in all
canonical cytoplasmic and bacterial species. For example, most
mitochondrial tRNAs do not possess one or more of the
conserved nucleotides necessary to form tertiary contacts
between the D- and T-loops in the globular hinge region of
the molecule (Figure 1A). Some other mitochondrial species,
including all the mammalian tRNASer acceptors, are missing large
portions of the D-arm that appear necessary to the structural
integrity of the tertiary core (Figure 1A).37,38 The absence of
these otherwise highly conserved structural features correlates
with the general instability of mitochondrial tRNAs and may
account for why none of these species has been successfully
crystallized.
We show here that the native state stability of unmodified hmt
tRNALeuUAA is only about 7.3-fold higher than that of a kinetic on-
pathway, non-native intermediate. This intermediate is unstable
and readily refolds to the native state, but because the native state
is only marginally more stable than the intermediate, there is a
small but consistent accumulation of intermediate at equilibrium.
Strikingly, we show that the native state can also periodically
unfold to form the intermediate state even at high Mg2+
concentrations. This creates a steady exchange of conformations
where native and intermediate states are constantly sampled. In
contrast to the unmodified tRNA, the dynamic exchange of
conformations in the fully modified form of bovine mitochon-
drial (bmt) tRNALeu is restricted. Our model suggests that the
dynamicity to populate native and non-native species during
folding is an important feature of weakly stable RNAs.
■ EXPERIMENTAL PROCEDURES
Hmt and bmt mitochondrial tRNALeuUAA were prepared by in
vitro transcription. In vivo, post-transcriptionally modified bmt
tRNALeu was isolated from fresh bovine liver as described
previously.39
LARS2 Purification. LARS2 was overexpressed in E. coli and
purified as described previously.40 The vector was transformed
into Rosetta 2(DE3)pLysS competent cells (Novagen). The
overnight culture was added to 1 L of LBmedia in the presence of
Figure 1. Aminoacylation of hmt tRNALeuUAA. (A) Secondary structure
of Hmt tRNALeuUAA. A−U pairs are highlighted in blue, A−C
mismatches in yellow, and the G−U pair in pink. (B) Hmt tRNALeuUAA
was incubated in 20 mM Mg2+, 2.5 mM ATP, and 10 mM leucine for 5
min. The aminoacylation reaction was then initiated by the addition of 5
μM LARS2. The inset shows a TLC image of the reaction following P1
nuclease digestion of the tRNA to nucleotides and separation; Leu-Ap*
and Ap* represent leucylated and nonleucylated tRNALeuUAA,
respectively. These spots were quantitated, and the fractions of
leucylated tRNAs were plotted over time to determine the maximum
plateau value for aminoacylation at 93% (∇). A small fraction (about 5−
10%) cannot be aminoacylated, most likely because of 3′-end
heterogeneity and/or damage during the synthesis and labeling steps.
(C) tRNA was first heat-denatured and then slow cooled to 21 °C; (D)
tRNA was folded at 21 °C without heat-denaturation. Reactions in C
and D were performed in the presence of 10 mM Mg(CH3COO)2
followed by the addition of 500 nM LARS2. Data depicted in panels C
and D are derived from aminoacylation reactions performed at 15 °C
(∇), 21 °C (Δ), 37 °C (○), and 45 °C (□). The highest plateau levels
were obtained when the tRNA was both folded and aminoacylated at 21
°C. These experiments demonstrate that conventional refolding by heat-
denaturation followed by slow cooling or aminoacylation at 37 °C or
higher each give low aminoacylation plateau levels.
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35 μg/mL chloramphenicol and 34 μg/mL kanamycin. After the
culture was grown at 37 °C to A600 of 0.8, expression was induced
with 1 mM IPTG, and cells were then allowed to grow overnight
at 15 °C. The cells from 1 L of saturated culture were centrifuged
and resuspended in 35 mL of lysis buffer containing 20 mM
sodium Hepes (pH 7.2) and 500 mM NaCl, followed by the
addition of 150 μg of DNase I, 50 mg of lysozyme, and one pellet
protease inhibitor [Complete Mini, ethylenediaminetetraacetic
acid (EDTA)-free protease inhibitor cocktail tablets, Roche
Diagnostics, GmbH, Germany]. The cells were sonicated for 15
min with an alternating 10 s pulse on/pulse off mode. The cell-
free lysate was then centrifuged at 16,000 rpm for 45 min, and the
supernatant was applied to a 2mLNi-NTAmatrix PerfectProNi-
NTA Agarose (5 PRIME) column pre-equilibrated in lysis buffer
(20 mM sodium Hepes (pH 7.2), 500 mM NaCl, 10 mM
imidazole, and 5 mM β-mercaptoethanol). The column was then
washed sequentially with 30 column volumes of lysis buffer, 10
column volumes of buffer containing 20 mM imidazole, and
finally with 2 column volumes of buffer containing 30 mM
imidazole. Pure LARS2 was then eluted using a 250 mM
imidazole. The protein was dialyzed against and stored in a buffer
containing 25 mM Hepes-KOH (pH 7.2), 150 mM KCl, 5 mM
β-mercaptoethanol, 0.2 mM EDTA, and 50% glycerol.
Purification and 3′-End Repair of BovineMitochondrial
tRNALeuUAA. In vivo, fully post-transcriptionally modified bovine
mitochondrial tRNALeuUAA was isolated from fresh bovine liver as
described previously.39 The isolated tRNA possessed a truncated
3′-terminus possessing a cyclic phosphate (3′ CC > p), which
was hydrolyzed by treatment with 0.1 M HCl for 3 h on ice. The
acid-treated tRNA was then recovered by ethanol precipitation.
Next, the tRNA was denatured by heating at 70 °C for 7 min and
annealed at room temperature in a buffer containing 50 mM
HEPES-KOH (pH 7.5) and 10 mMMgCl2. After the addition of
5 mM DTT, the 3′-end of tRNA was dephosphorylated by the
action of the 3′-phosphatase activity in T4 polynucleotide kinase
(30 U/1 OD unit of tRNA, Toyobo). The 3′-end of the tRNA
was then repaired with E. coli tRNA nucleotidyltransferase (5 μg/
1OD unit of tRNA) in a reaction consisting of 33.4 mMHEPES-
KOH (pH 7.5), 100 mM KCl, 6.6 mMMgCl2, 1.67 mMDTT, 1
mM ATP, and 1 mM CTP.41 The repaired tRNA was extracted
with Tripure Isolation Reagent (Roche) as instructed by the
manufacturer and gel-purified on a 10% polyacrylamide gel
containing 7 M urea. Finally, the tRNA was desalted by drop
dialysis with MF-membrane filters (Millipore, 0.025 μm VSWP
membrane). To check the quality of the 3′-terminus, the purified
tRNA was digested by Interferase-MazF (TaKaRa) and
subjected to liquid chromatography−mass spectrometry to
observe the 3′-terminal fragments,42 confirming that the 3′-
terminus of the tRNA was fully repaired.
Activity Assay to Probe Equilibrium and Kinetics of
Folding/Unfolding of tRNALeuUAA.
32P-labeled tRNALeu
species with the label located at the 3′-internucleotide linkage
were prepared as described previously for the transcript of E.coli
tRNAGln.43 All aminoacylation reactions were performed in the
presence of 100 mM Na-Hepes (pH 7.0), 5 mM DTT, 10 mM
leucine, 2.5 mM ATP-Mg(CH3COO)2, and the specified
concentration of Mg(CH3COO)2. For equilibrium reactions,
tRNALeuUAA was preincubated with Mg
2+ (or Mg2+ and EDTA)
for 30 min and the reaction initiated by the addition of LARS2.
For monitoring rate-limited folding to the native state,
tRNALeuUAA was preincubated in the absence of Mg
2+ ions, and
the reaction was initiated with the simultaneous addition of
LARS2 and Mg2+. For monitoring the unfolding reaction, a two-
stage unfolding and aminoacylation reaction was set up. In the
first stage, unfolding of tRNALeu was initated by the addition of
EDTA to Mg2+-preincubated tRNALeu; in the second stage,
aliquots from this mixture were aminoacylated with the addition
of LARS2 for 15 s. Reactions were quenched in 400 mM sodium
acetate (pH 5.2) with 0.1% SDS, followed by the addition of P1
nuclease to 0.1 mg/mL and incubation for 10 min. Aliquots were
spotted on previously water run and dried polyethyleneimine-
cellulose thin-layer chromatography plates (Sigma). The plates
were developed in 100 mM ammonium acetate and 5% (v/v)
acetic acid, dried, and exposed to phosphorimaging screens
overnight. Spots corresponding to [32P]-labeled Leu-AMP and
AMP were quantitated with ImageQuant (version 5.2), and the
data were plotted in Kaleidagraph (version 4.03). All experiments
were repeated at least twice, and the error rates are <10%.
SHAPE Analysis of Transcript hmt tRNALeu. SHAPE
analysis footprinting experiments were conducted as described
previously.44N-Methylisatoic anhydride (NMIA) was purchased
from Sigma. A final concentration of 10 mM NMIA, which
produces single-hit conditions as judged by the observation of
full-length bands, was incubated with the tRNA construct at 30
°C for 1 h before ethanol precipitation and primer extension as
described.44 1M7 analysis was performed similarly. DNA for in
vitro transcription containing a T7 RNA polymerase binding site,
5′ linker, tRNALeuUAA, 3′-linker, and reverse transcriptase binding
site, in that order, was constructed using an Assembly PCR oligo
maker.45 Recursive gene synthesis was performed employing
VENTDNA polymerase.46 RNAwas then prepared using in vitro
transcription and gel purification.
■ RESULTS
To study the structural dynamics of a weakly stable RNA in
detail, we selected the hmt tRNALeuUAA species that has
previously been examined by structure probing and amino-
acylation experiments.47,48 This isoacceptor is one of the few
mitochondrial tRNAs in humans possessing all of the conserved
elements required for canonical tRNA tertiary folding (Figure
1A).49 However, the unmodified transcript nonetheless does not
adopt a canonical L-shaped structure at 37 °C and 12 mM
Mg2+,47 perhaps owing to the presence of a high proportion of
A−U base pairs and a few A−C mismatches in the helical stem
regions (Figure 1A). Footprinting experiments showed that
under these conditions the acceptor and T stems are fully
formed, but the D and anticodon stems comprising the vertical
arm were unstructured. Despite this, the tRNA remained
aminoacylable at levels up to 75%.47,48 These findings suggested
two alternative possibilities for the aminoacylation mechanism:
(i) 75% of the partially structured transcript tRNA adopts the
native and functional structure upon binding to leucyl-tRNA
synthetase (LARS2) so that the enzyme functions as a folding
chaperone; (ii) 75% of transcript tRNA is dynamic, such that
unstructured tRNA transiently populates a canonical native
structure that is then captured and aminoacylated by LARS2.
Optimal Folding and Aminoacylation of the hmt
tRNALeu Unmodified Transcript. To address the folding
dynamics of tRNALeu, we employed a sensitive assay that
accurately distinguishes the native aminoacylable form of the
tRNA from all other conformers.36,50 The hmt tRNALeu
transcript was 32P-labeled at the 3′-internucleotide linkage as
described previously36,51 and then allowed to fold by incubation
at 21 °C with the further addition of 20 mMMg2+(acetate). The
capacity of the tRNA to serve as a substrate for aminoacylation by
LARS2 was then evaluated at 21 °C, in the presence of 2.5 mM
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ATP and 10 mM leucine (Leu) (Figure 1B). These optimized
reaction conditions permit maximum aminoacylation plateau
levels of 90−95%, higher than previously reported for any
organellar tRNA transcript.47 Further, neither the rate nor
amplitude of aminoacylation was affected by preincubation of
LARS2 with tRNA, suggesting that the enzyme does not function
as a folding chaperone. These optimized folding conditions allow
accurate determination of kinetic and thermodynamic parame-
ters for tRNA folding, as described below. More conventional
refolding protocols involving heat-denaturation and annealing
steps, higher temperatures in aminoacylation, or use of chloride
as the counterion gave lower aminoacylation plateau levels
(Figure S1, Supporting Information), perhaps in part because of
structural destabilization at high temperatures (Figures 1C,D and
S2 (Supporting Information)). It is also known that acetate
anions are generally less inhibitory to protein−RNA interactions
as compared with chloride.52
Stability of the hmt tRNALeuUAA Unmodified Transcript.
To evaluate the stability of hmt tRNALeu, we monitored the
equilibrium fraction of native tRNA at varying Mg2+ ion
concentrations under our optimized solution conditions (Figure
2A). Control experiments established that incubation of the
tRNA for 30 min sufficed to reach equilibrium (data not shown).
We then performed aminoacylation reactions on the pre-
equilibrated mixture. At all Mg2+ concentrations, we observed
biphasic kinetics with a rapid initial phase of aminoacylation
followed by a slower phase (Figure 2A). In accordance with our
detailed folding studies of archaeal tRNAGln,36 in which identical
biphasic behavior was observed, we infer that the fast phase
represents aminoacylation of already-folded species, while the
slow phase represents aminoacylation of species that fold to the
functional, aminoacylable state after the enzyme is added. The
slow phases at lower Mg2+ concentrations (below 20 mM)
exhibit lower plateaus than the maximum value observed at and
above 20 mM Mg2+. This indicates that at equilibrium larger
fractions of tRNA do not fold to the native state at lower Mg2+
concentrations. Below we demonstrate that LARS2 is able to
fully aminoacylate modified tRNA at low Mg2+; thus, the lower
plateau values do not represent enzyme inactivation under these
conditions. At the higher Mg2+ concentrations, the maximum
aminoacylable fraction is 94%, and themaximum burst amplitude
is 0.83. Because a small fraction, approximately 6%, represents
damaged and nonaminoacylable tRNA, the true fraction of native
tRNA represented in the burst amplitude is 0.88 ± 0.01 after
normalization.
Two sets of experiments were performed to determine if the
high and stable maximum normalized burst amplitude of 0.88 ±
0.01 at 20 mM Mg2+ and higher represents the true equilibrium
for the native state (Figure 3). We performed aminoacylation
reactions by first incubating tRNALeu in the presence of 20 mM
Mg2+ for 20 min and then adding varying concentrations of
EDTA, an agent that chelates divalent metal ions. If the burst
amplitudes indeed represent equilibrium fractions of native
species, then we would expect to observe a decrease in burst
amplitudes as EDTA concentrations are increased. In contrast, if
bursts arise from a kinetic effect, then EDTA concentrations
should have little or no influence on the amplitudes while
perhaps affecting the rate of the slow phase. The data
demonstrate that a decrease in burst amplitudes is indeed
observed upon addition of EDTA, without any effect on the slow
phase rate (Figure 3A). Thus, the amplitudes represent native
fractions at equilibrium. The plot of burst amplitudes against
Mg2+ concentrations shows that tRNALeu requires a very high
concentration of Mg2+ ions (Mg1/2 = 6.55 mM) to fold to the
native state (Figure 2B; a small fraction of Mg2+ may remain
associated with acetate at high concentrations (>40 mM),53
thereby slightly overestimating the Mg1/2). These results are in
striking contrast to those observed for several canonical in vitro
transcribed tRNAs in which Mg1/2 was found to be 0.02−1
mM.54,55 Thus, consistent with previous findings, these results
suggest that the hmt tRNALeu transcript is highly destabilized
compared to canonical tRNAs, despite its conventional cloverleaf
secondary structure.
In the second set of experiments, we preincubated hmt
tRNALeuUAA in K
+-Hepes buffer before simultaneously adding
Mg2+ ions and LARS2, to initiate folding and aminoacylation at
the same time. These Mg2+-jump experiments isolate a rate-
limiting folding step: the biphasic plot (rapid phase of∼15 min−1
followed by a slow phase of ∼0.75 min−1) (Figures 2A and
3A,C), is replaced by a uniphasic plot with a rate-constant of 0.7
min−1 (Figure 3B). This rate constant is about 15-fold lower than
the aminoacylation rate constant for the fast phase under the
same conditions (Figure 3C), suggesting that a large fraction of
the tRNA either exists in non-native forms in the absence ofMg2+
ions or is converted to non-native forms immediately uponMg2+
addition. The refolding data fits well to a single exponential
function (Figure 3B), suggesting that the non-native species is
either a unique misfolded form or multiple misfolded forms that
behave kinetically as a single species. The non-native fractions
depicted in Figure 2A represent this misfolded species because
these fractions also fold to the native state with nearly the same
slow (approximately 1 min−1) rate constant (Figure 3B).
Because our results indicate that native and misfolded tRNAs
are present as kinetically distinct species, we were able to
quantitatively determine the extent to which the native
conformer is stabilized over the misfolded conformer. Since
the maximum fraction of native species that can be prefolded at
equilibrium corresponds to a burst amplitude of 0.88, we
calculate an equilibrium value of 7.3 for the native state over the
misfolded state [f = K/(1 + K)] or a difference of 1.2 kcal/mol at
21 °C. Thus, at equilibrium, a fraction corresponding to 7.3/8.3
Figure 2. Mg2+-dependent folding of the unmodified hmt tRNALeuUAA
transcript. (A) Results of leucylation reactions performed at different
concentrations of Mg2+ (as indicated on the right panel). The tRNA was
preincubated in 2.5 mM ATP, 10 mM Leu, and the indicated
concentrations of Mg2+ for 30 min before initiating the reaction with
the addition of 5 μM LARS2 at 21 °C. The maximum aminoacylable
fraction is 94%, and the maximum burst amplitude is 0.83. Because a
small fraction, here 6%, represents damaged and nonaminoacylable
tRNA, the true fraction of native tRNA at equilibrium is 0.88 after
normalization. (B) Plot of the normalized burst amplitudes from panel A
against Mg2+ concentration, giving Mg1/2 of 6.55 mM. This represents
the concentration at which half the hmt tRNALeuUAA is in the native state.
The data point X represents normalized burst amplitude from the plot in
Figure 1B.
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(88%) is in the native state, and 1/8.3 (12%) is misfolded. We
previously used the same strategy to obtain an equilibrium value
of 2.5 for the native state of an archaeal tRNAGln.36
Kinetic Intermediate during the Folding of Unmodi-
fied hmt tRNALeu.The observed slow folding behavior inMg2+-
initiated reactions prompted us to further investigate the
properties of the nonaminoacylable species. Specifically, we
wished to address whether this species requires a large activation
energy for folding to the functional conformation, as would be
generally expected for a kinetic intermediate that must first
undergo partial unfolding to access the native state. To examine
this, we measured the dependence of folding on temperature
(Figure 4A). The rate constant for tRNA refolding in Na+-
preincubated, Mg2+-initiated reactions is indeed highly depend-
ent on temperature: lower temperatures yielded lower rate
constants for folding. The dependence of rate on temperature
gave an apparent activation enthalpy of 32.8 kcal/mol (Figure S3,
Supporting Information), consistent with disruption of 10−19
base-pairs.56 In contrast, the rates for aminoacylation (fast phase)
of prefolded tRNALeu appear to be identical at all temperatures
tested. Thus, the misfolded form is a kinetic on-pathway
intermediate that requires disruption of the secondary/tertiary
structure and partial unfolding to fold to the native state.
Strikingly, the rate constants for the slow phases of amino-
acylation of the prefolded tRNAs were comparable to the rate
constants for refolding at all three temperatures tested (Figure 4,
legend). These observations are highly consistent with the
notion that the slow phase indeed represents the rate-limiting
folding step from the intermediate to the native state.
We also performed a partial urea-denaturation experiment to
determine if the kinetic intermediate unfolds by disruption of
base-pairs and tertiary contacts.11 We monitored the refolding of
tRNALeu at 10 °C as depicted in Figure 4A, except that the tRNA
was preincubated in 1 M urea prior to aminoacylation. This low
concentration was chosen based on previous studies on GlnRS
that demonstrated only negligible denaturing effects of 1 M urea
but required 18 h and much higher (>3 M) concentrations for
substantial denaturation.57 As shown in Figure 4B, we observed a
14-fold increase in the rate constant for refolding of tRNA under
these conditions. This suggests that during the process of
refolding of tRNA from the intermediate to the native state there
is substantial disruption of secondary and/or tertiary contacts.
Therefore, it seems clear that addition of urea accelerates
refolding to the native state. Additionally, we observed that the
plateau value in the presence of urea was reduced from 0.86 to
0.59, suggesting that either the denaturant also partially unfolds
the native state under the solution conditions tested or that urea
stabilizes a completely unfolded fraction that is unable to fold to
the native state.
Dynamic Exchange of Conformations between Native
and Intermediate States. The equilibrium value of 7.3 for the
native state relative to the intermediate, together with an
Figure 3. Interpretation of the burst amplitudes. (A) tRNAwas preincubated in 20mMMg2+, 2.5 mMATP, 10mMLeu, and EDTA concentrations of 0
mM (∇), 2.5 mM (Δ), 5 mM (○), 7.5 mM (□), 10mM (◊), 12.5 mM (×), and 25mM (●) for 30min before initiating the reaction with the addition of
5 μM LARS2. The decrease in burst amplitudes reflects reduction in prefolded native tRNAs due to the decrease in free Mg2+ ion concentration as the
concentration of EDTA is increased. (B) Transcript tRNALeuUAA was preincubated either in the absence (○) or presence of 3 mMMg
2+ (Δ) or 50 mM
Mg2+ (∇), before simultaneously initiating the reaction with 5 μMLARS2 and readjusting theMg2+ concentration to 50 mM for all three reactions. Rate
constants were 0.7 min−1 (○) and 1.3 min−1 (Δ). Rate constants for fast (measured separately) and slow phases were 15 min−1 and 1 min−1 (∇),
respectively. The normalized Y-intercepts corresponding to prefolded tRNA are 0.86 (∇) and 0.34 (Δ). (C) Rapid aminoacylation of preincubated
tRNALeuUAA. tRNAwas preincubated in 20 mMMg(CH3COO)2, 10 mMLeu, 2.5 mMATP-Mg(CH3COO)2, 5 mMDTT, and 100mMHEPES-KOH.
The reactions were initiated bymixing with either 1 μM(Δ) or 5 μMLARS2 (∇) using rapid quenching. kobs were 0.22 s−1 (13.2min−1) or 0.27 s−1 (16.2
min−1) for reactions at 1 μM and 5 μM enzyme, respectively.
Figure 4. Dependence of folding on temperature and denaturant. (A)
hmt transcript tRNALeuUAA was either preincubated in 100 mM Na
+-
Hepes (open symbols) or prefolded in 100 mMNa+-Hepes and 50 mM
Mg2+ (solid symbols) at 10 °C (blue), 15 °C (red), or 21 °C (green)
before initiating the reaction with the addition of 5 μM LARS2.
Reactions preincubated in the absence of Mg2+ fit well to single
exponential functions giving rate constants of 0.05 min−1, 0.16 min−1,
and 0.5 min−1 at 10, 15, and 21 °C, respectively. The reactions
preincubated in the presence of Mg2+ (solid symbols) were best fit to
double exponential functions, with the rates of slow phases being 0.08
min−1, 0.13 min−1, and 0.7 min−1 at 10, 15, and 21 °C, respectively. (B)
Hmt transcript tRNALeuUAA was allowed to refold at 10 °C as in panel A
(○) or was preincubated in 1 M urea before initiating the reaction with
LARS2 (●). kobs derived from the data are 0.03 min
−1 (○) and 0.43
min−1 (●).
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observed rate of refolding of 0.75 min−1 for conversion of the
intermediate to the native conformation (Figure 2A, 3), allowed
calculation of the individual forward and reverse rate constants as
0.66 min−1 and 0.09 min−1, respectively. The data are consistent
with a two-step model in which addition of Mg2+ ions results in
formation of a kinetic intermediate, which then refolds to the
native state. However, because the native state is only marginally
more stable, and the kinetic barrier between states is low at 21 °C
or higher, it appears possible that the native state alsomay unfold,
albeit less frequently, to form the intermediate. This would
generate a steady sampling of conformations at defined rates at
equilibrium (Scheme 1). In a two-state model, the approach to
equilibrium from native to intermediate should produce the same
observed rate constant as that for folding of the intermediate to
the native state (about ∼0.75 min−1).
To test this prediction, we directly monitored unfolding of the
native state by taking advantage of the fact that addition of EDTA
reduces the free Mg2+ ion concentration but does not affect the
rates of the folding and unfolding transitions. Thus, we prefolded
the tRNA at a concentration of 20 mM Mg2+ and then titrated
EDTA into this prefolded mixture at 21 °C (Figure 5A). At each
concentration of EDTA tested, we indeed observed small but
consistent decreases in the fraction of native state that is
populated over time, following EDTA addition. In each case, the
data fit well to a single exponential function yielding a rate
constant of about 1 min−1 (Figure 5B). Unfolding was observed
at 5−12.5 mM EDTA concentrations; at 2.5 mM EDTA, the
equilibrium is not perturbed, and thus no unfolding was
observed. Thus, the native and intermediate states are engaged
in a dynamic exchange of conformations with the equilibrium
slightly favoring the native state over the intermediate.
To provide a structural basis for the observed folding
dynamics, we next performed selective 2′-hydroxyl acylation
analyzed by primer extension (SHAPE) experiments, using N-
methylisatoic anhydride (NMIA) as a probe (Figure 6). At 30 °C
and 40 mM MgCl2, we observed extensive reactivities of the
anticodon stem and variable loops. Absolute reactivities at these
nucleotides are above 16% at both bases of a pair and thus are
more flexible (Figure 6). We also performed SHAPE experi-
ments in the presence of the reagent 1M7, which is not
influenced by the presence of high MgCl2 (>40 mM); these
reactions were performed at 0, 12, and 50mMMgCl2 (Figure S4,
Supporting Information). On the basis of the presumption that
base-pairs are stabilized at higher concentrations of Mg2+, we
inferred that bases showing decreased reactivity as the Mg2+
concentration was increased are unpaired at the lower
concentrations. The structural model obtained from this analysis
shows an unpaired anticodon stem and variable loop region,
whereas other parts of the tRNA appear to be well formed. These
data are consistent with earlier findings for this tRNA, in which
the anticodon and D-stems showed extensive reactivities in
nuclease footprinting assays.47 Thus, the structural dynamics are
confined to the tRNA vertical arm. Analysis of this tRNA using
the secondary structure prediction algorithm MC-fold suggested
that an elongated structure containing an intact acceptor stem
and T-stem, but mispaired D and anticodon stems, is most stable.
Predicted suboptimal structures also exhibited these character-
istics (Figure S5, Supporting Information). Thus, we propose
that the kinetic intermediate features an intact acceptor stem and
T-stem, and non-native secondary structure in other parts of the
molecule (Figure 7).
Post-TranscriptionalModifications Stabilize theNative
State of Bovine Mitochondrial tRNALeu. The influence of
post-transcriptional modifications on dynamics was investigated
for the related bmt tRNALeu. This tRNA is structurally very
similar to hmt tRNALeu and possesses an identical set of
modifications in the globular core domain (Figure S6,
Supporting Information). The human enzyme LARS2 efficiently
aminoacylates both the unmodified transcript and the fully
modified bmt tRNALeu isolated from bovine tissue (Figure 8).
The unmodified bmt tRNALeuUAA transcript exhibited dynamic
folding behavior similar to hmt tRNALeuUAA, with a persistent
slow phase of refolding at equilibrium and in Mg2+-jump
experiments (Figure 8A,B). Thus, the folding behavior of the
bmt tRNA is also consistent with a model of kinetic
intermediates refolding to the native state.
We compared the Mg2+ ion dependence of folding between
modified and unmodified bmt tRNALeu. We observed that in vivo
tRNA prepared in the absence of Mg2+ is partially folded in the
absence of externally added Mg2+ (Figure 8C). In contrast to the
unmodified tRNA, the time courses for folding of modified tRNA
at all Mg2+ concentrations showed no slow phases within the 10−
20 s time limit of manual pipetting. These results suggest that the
post-transcriptionally modified tRNA does not engage in slow
exchange of conformations on a time scale comparable to that of
the unmodified transcript. Further, the modified tRNA requires
much less Mg2+ for folding to the native state at equilibrium
(Mg1/2 of 0.59 versus 2.23mM) (Figure 8D). This effect is clearly
attributable to the increased stability afforded by the presence of
the post-transcriptional modifications.
■ DISCUSSION
The structural dynamics of weakly stable RNAs and the role of
intermediates during folding have not previously been well-
documented. Here, we exploited the known weak local stability
of the anticodon arm of unmodified hmt tRNALeuUAA (Figure
1A) to address these issues. Using a sensitive aminoacylation-
based folding assay, we show that the local structural fragility
Scheme 1
Figure 5. Monitoring unfolding of Hmt tRNALeuUAA. (A) Scheme for
unfolding experiment. (B) Unfolding was initiated by the addition of 2.5
mM (◊), 5 mM (□), 7.5 mM (Δ), 10 mM (∇), and 12.5 mM (○)
EDTA to tRNALeuUAA preincubated in the presence of 20 mMMg
2+ for
30 min. Aliquots from this folding reaction were added to LARS2 (5
μM) in separate tubes and incubated for exactly 15 s before quenching
with 1% SDS, followed by P1 nuclease digestion. The rate constants
were about 1 min−1 at all concentrations of Mg2+.
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Figure 6. SHAPE footprinting with the sequencing lanes (U, C, G, and A) labeled at every 5 nucleotides. DMSO lane (solvent only) control lane and
NMIA (SHAPE reagent) lanes are also shown. The U, C, G, and A sequencing ladder lengths are exactly one nucleotide longer than the corresponding
DMSO and +NMIA product lengths. (A) The experiment demonstrates extensive reactivities of the D-stem, anticodon stem, and variable loops of hmt
tRNALeuUAA at 30 °C and 40 mMMgCl2. (B) Proposed structural model based on the SHAPE experiments. Absolute SHAPE intensities were binned
into 0−15%, 16−50%, and >50%, and corresponding nucleotides are color-coded. (C) Absolute SHAPE reactivities were calculated from subtracting the
intensities in the DMSO lane from those in the +NMIA lane.
Figure 7. Proposed model for hmt tRNALeu dynamics. Nucleotide residues are color-coded based on SHAPE intensities as described in Figure 6.
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results in a highly destabilized global structure, as the tRNA
requires a very high concentration of Mg2+ ions (Mg1/2 = 6.55
mM) to fold to the native conformation. We then demonstrate
that the degree of destabilization is such that the native state is
only about 7.3-fold (1.16 kcal/mol) more stable than a kinetic
intermediate. Thus, the unmodified hmt tRNALeu cannot
populate the native state exclusively. Our results also suggest
that the physiological temperature of 37 °C may be too high to
stably populate native in vitro transcribed tRNAs for folding
studies. Therefore, optimal temperature and solution conditions
may have to be empirically determined for individual
mitochondrial tRNAs as demonstrated in this study.
Since LARS2 does not influence either the thermodynamic
equilibrium between native and intermediate, or the rate of
folding, it appears unlikely that the enzyme functions as a
chaperone. In the case of hmt tRNALeu, pathological disease
mutations are located throughout the D and anticodon arms.58,59
It is possible that the preponderance of disease mutations in
these portions of the tRNA arises because the mutations further
destabilize the already weakly stable native state, shifting the
equilibrium to the misfolded intermediate. Mutations might also
affect the folding dynamics such that both the native and
intermediate are poorly populated, thereby reducing the ability of
modification enzymes to recognize either form of the molecule.
In fact, the most common disease-causing mutation, the A3243G
alteration that is implicated in MELAS disease, results in the
absence of a crucial taurine modification at position 34 without
any change in other modifications, possibly because A3243G
selectively alters the folding pathway.60
We also find that the kinetic barrier between the intermediate
and the native state is sufficiently low that the two species can
readily interconvert. The refolding of intermediate to the native
state is much faster at higher temperature, as expected for a
kinetically trapped species possessing non-native contacts.
SHAPE analysis, structural predictions using MC-fold, and
prior data47 consistently demonstrate that the acceptor/T-stems
of the unmodified tRNA are stable so that the destabilization is
localized to the vertical anticodon arm. The non-native duplex
structure predicted in the intermediate requires unwinding to
allow for the formation of the D and anticodon stem structures in
the native tRNA. This is consistent with the slow temperature-
dependent refolding observed during conversion of the
intermediate to the native state.
In general, in vivo folding of RNAs is faster than tran-
scription;61 therefore, a dynamic structure may prevent RNAs
from becoming trapped in a local conformation. The sampling of
conformations by unfolding to and refolding of a kinetic
intermediate is likely in vivo because the dynamics we have
observed occurs at physiological Mg2+ concentrations of 1−5
mM. Our results suggest that at very low Mg2+ concentrations
only a fraction of the tRNA folds to the native state, while the
remainder remains either unfolded or partially folded. Even the
small fraction that folds to the native state at low Mg2+ levels
shows sampling of conformations between native and the
intermediate states. Thus, cells could modulate dynamics of
tRNAs by altering concentrations of Mg2+ or possibly also of
polyamines such as spermine.62
Figure 8. Effect of modifications on native state stability and dynamics of bmt tRNALeu. (A) Leucylation reactions of the bmt tRNALeuUAA transcript
performed at different concentrations of Mg2+. The tRNA was preincubated in 2.5 mM ATP, 10 mM Leu, and the indicated concentrations of Mg2+ for
30 min before initiating the reaction with the addition of 5 μMLARS2. (B) Leucylation reaction of bmt tRNALeuUAA transcript preincubated either in the
absence or presence of 20 mMMg2+, before simultaneously initiating the reaction with 5 μMLARS2 and readjusting the Mg2+ concentration to 20 mM
Mg2+. Rate constants for the slow phases were 1.27 min−1 (Δ) and 1.42 min−1 (∇), and the Y-intercepts were 0.53 and 0.86, respectively. The rate
constants for the fast phases were too fast to be measured by manual pipetting. (C) Leucylation reactions of modified bmt tRNALeu isolated from cells,
performed as described for panel A. (D) Plot of the normalized fraction of the native state as a function of Mg2+ concentration. The half-maximumMg2+
concentrations for folding to the native state (Mg1/2) are 0.59 mM for modified tRNA and 2.23 mM for the unmodified transcript tRNA.
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As we have also demonstrated, post-transcriptional mod-
ifications can affect the equilibrium distribution of unfolded,
partially folded, and native species in tRNA.36,63 We suggest then
that the recognition of bases and ribose sugars in the globular
hinge domain of tRNA may depend upon an intrinsic dynamic
instability of the tertiary structure in this region. For example,
archaeosine tRNA-guanine transglycosylase (ArcTGT) converts
G15 in the core region to the archaeosine precursor 7-cyano-7-
deazaguanine (preQ0). The cocrystal structure of ArcTGT
shows that the tRNA core region is completely disrupted, with
the tRNA adopting an extended conformation when bound to
the enzyme.64 Dynamic unfolding and refolding of the
unmodified tRNA could thus play a central role in the efficiency
of the enzyme.
The finding that weakly stable RNAs can dynamically
exchange between specific conformations may also have strong
implications for functions of RNAs that follow a simple two-step
folding−unfolding processes, including riboswitches. For exam-
ple, the Trp terminator/antiterminator element contains multi-
ple CUG triplets thought to destabilize the formation of stable
duplexes and allow for efficient Trp-dependent switching from
antiterminator to terminator structures.65 Another example is
translational frameshifting on the ribosome, in which control by
RNA depends not only on the formation of a folded pseudoknot
structure but also on partial unfolding of the pseudoknot to
hairpins.66 Thus, dynamic exchange by lowering of stabilities




Magnesium acetate gives higher plateau charging values for hmt
tRNALeuUAA transcript compared to magnesium chloride;
aminoacylation plateau value is low at higher temperature
(>37°C) for hmt tRNALeu; log-linear plot of the rate constant
against 1/T (K) for folding of the hmt tRNALeuUAA transcript;
1M7 SHAPE analysis at differentMg2+ concentrations; predicted
optimal (upper left) and sub-optimal secondary structures of hmt
tRNALeuUAA transcript tRNA; and predicted native secondary
structures (based on comparative sequence analysis) of human
and bovine transcript tRNALeuUAA. This material is available free
of charge via the Internet at http://pubs.acs.org.
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